Predicting cyclins based on key features and machine learning methods
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies key physicochemical features for distinguishing cyclins from non-cyclins using machine learning. A model using just two features achieved good prediction accuracy, improving interpretability in cyclin identification.
Area Of Science
- Molecular Biology
- Biochemistry
- Computational Biology
Background
- Cyclins are essential proteins regulating the cell cycle, crucial for cell proliferation, differentiation, and apoptosis.
- Understanding cyclin functions and dysfunctions is vital for cell biology and pathology.
- Existing machine learning models for cyclin identification prioritize accuracy over feature interpretability.
Purpose Of The Study
- To develop an interpretable machine learning model for cyclin identification.
- To analyze and identify key physicochemical features distinguishing cyclins from non-cyclins.
- To assess the predictive power of these key features in cyclin classification.
Main Methods
- Support Vector Machine (SVM) model construction for cyclin identification.
- 5-fold cross-validation for initial model performance evaluation.
- Analysis of physicochemical properties of 14 key features.
- Leave-one-out cross-validation for a reduced feature set model.
Main Results
- An SVM model achieved 92.8% accuracy in cyclin identification using 5-fold cross-validation.
- The G and charged C1 features were identified as critical for distinguishing cyclins.
- An SVM model utilizing only the G and charged C1 features reached 81.3% accuracy via leave-one-out cross-validation.
Conclusions
- Cyclins exhibit distinct physicochemical properties compared to non-cyclins.
- A reduced set of key features can achieve significant predictive accuracy in cyclin identification.
- This approach enhances the interpretability of machine learning models in cyclin research.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...